相似文献
1
Risk stratification for melanoma.黑色素瘤的风险分层
Oncotarget. 2019 Mar 8;10(20):1868-1869. doi: 10.18632/oncotarget.26755.
2
Comparison of dermatoscopic ABCD rule and risk stratification in the diagnosis of malignant melanoma.皮肤镜检查的ABCD规则与风险分层在恶性黑色素瘤诊断中的比较
Acta Derm Venereol. 2000 Mar-Apr;80(2):122-6.
3
Commentary: The quest for an improved risk stratification tool for patients with melanoma.评论：寻求一种改进的黑色素瘤患者风险分层工具。
J Am Acad Dermatol. 2017 May;76(5):826-828. doi: 10.1016/j.jaad.2017.02.045.
4
Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.黑色素瘤长链非编码RNA特征预测预后生存并指导临床风险特异性治疗。
J Dermatol Sci. 2017 Mar;85(3):226-234. doi: 10.1016/j.jdermsci.2016.12.006. Epub 2016 Dec 5.
5
Further evidence supporting the need for improved risk stratification of thin melanoma.进一步的证据支持了对薄型黑色素瘤进行改进风险分层的必要性。
J Plast Reconstr Aesthet Surg. 2017 Jul;70(7):967-968. doi: 10.1016/j.bjps.2017.03.008. Epub 2017 Apr 6.
6
Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations.前哨淋巴结阳性黑色素瘤患者的风险分层决定了手术管理和辅助治疗的考虑因素。
Eur J Cancer. 2018 Jun;96:25-33. doi: 10.1016/j.ejca.2018.02.022. Epub 2018 Apr 13.
7
Defining the patient at high risk for melanoma.定义黑素瘤高危患者。
Int J Dermatol. 2010 Apr;49(4):362-76. doi: 10.1111/j.1365-4632.2010.04381.x.
8
Prognostic stratification of ulcerated melanoma: not only the extent matters.溃疡性黑色素瘤的预后分层：重要的不仅是范围。
Am J Clin Pathol. 2014 Dec;142(6):845-56. doi: 10.1309/AJCPW56PHGLFTKZC.
9
Biomarker use is associated with reduced clinical trial failure risk in metastatic melanoma.生物标志物的使用与转移性黑色素瘤临床试验失败风险的降低相关。
Biomark Med. 2015;9(1):13-23. doi: 10.2217/bmm.14.80.
10
Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.评估一种新的评分系统，用于预测前哨淋巴结阳性黑色素瘤患者中的非前哨淋巴结阳性。
Eur J Surg Oncol. 2013 Feb;39(2):179-84. doi: 10.1016/j.ejso.2012.10.014. Epub 2012 Nov 6.
本文引用的文献
1
Risk Stratification for Melanoma: Models Derived and Validated in a Purpose-Designed Prospective Cohort.黑色素瘤风险分层：在目的设计的前瞻性队列中得出和验证的模型。
J Natl Cancer Inst. 2018 Oct 1;110(10):1075-1083. doi: 10.1093/jnci/djy023.
2
Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.通过专门的高风险黑色素瘤患者诊所进行皮肤监测的成本效益。
J Clin Oncol. 2017 Jan;35(1):63-71. doi: 10.1200/JCO.2016.68.4308. Epub 2016 Oct 28.
3
Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.德国的皮肤癌筛查。记录2008年至2013年黑色素瘤的发病率和死亡率。
Dtsch Arztebl Int. 2015 Sep 18;112(38):629-34. doi: 10.3238/arztebl.2015.0629.
4
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.极高风险个体原发性黑素瘤的检测：一项前瞻性 5 年随访研究。
JAMA Dermatol. 2014 Aug;150(8):819-27. doi: 10.1001/jamadermatol.2014.514.
5
Risk prediction models for melanoma: a systematic review.黑色素瘤风险预测模型：一项系统综述。
Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1450-63. doi: 10.1158/1055-9965.EPI-14-0295. Epub 2014 Jun 3.
6
Risk prediction models for incident primary cutaneous melanoma: a systematic review.原发性皮肤黑色素瘤发病风险预测模型：系统评价。
JAMA Dermatol. 2014 Apr;150(4):434-44. doi: 10.1001/jamadermatol.2013.8890.
7
International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?国际恶性黑色素瘤发病率趋势 1953-2008 年——最近几代人面临的风险更高还是更低？
Int J Cancer. 2013 Jan 15;132(2):385-400. doi: 10.1002/ijc.27616. Epub 2012 May 21.
8
Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force.皮肤癌筛查：美国预防服务工作组证据更新
Ann Intern Med. 2009 Feb 3;150(3):194-8. doi: 10.7326/0003-4819-150-3-200902030-00009.
Zotero 插件